Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 studySylvie Castaigné, Hervé Dombret, Cécile Pautas et al.|The Lancet|2012Cited by 994
Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaPaul Nathan, Sophie Piperno‐Neumann, Anthony M. Joshua et al.|New England Journal of Medicine|2021Cited by 869
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 StudyRathana Kim, Emmanuelle Clappier, Yves Chalandon et al.|Journal of Clinical Oncology|2024Cited by 39
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint‐Ghislain, Manuel Rodrigues, Anne‐Céline Derrien et al.|European Journal of Cancer|2022Cited by 37
<i>MBD4</i> deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study.Mathilde Saint‐Ghislain, Manuel Rodrigues, Lionnel Geoffrois et al.|Journal of Clinical Oncology|2022Cited by 2